Stem cell transplant maintains benefit for multiple myeloma in era of novel agents – Healio
|
Stem cell transplant maintains benefit for multiple myeloma in era of novel agents
Healio Treatment with high-dose melphalan followed by autologous hematopoietic stem cell transplant conferred longer PFS with minimal toxic effects compared with novel agents among patients with multiple myeloma, according to results from a meta-analysis … |
